- Pirenoxine
-
- $1.10 / 1g
-
2025-06-25
- CAS:1043-21-6
- Min. Order: 1g
- Purity: 99.0% min
- Supply Ability: 100 tons min
- Pirenoxine
-
- $190.50 / 1g
-
2021-11-02
- CAS:1043-21-6
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 500g
- Pirenoxine
-
- $15.00 / 1KG
-
2021-07-13
- CAS:1043-21-6
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
|
| | Pirenoxine Basic information |
| Product Name: | Pirenoxine | | Synonyms: | Bernetine;catalin;1-Hydroxy-5-oxo-5H-pyrido[3,2-]phenoxazine-3-carboxylicacid;1-hydroxy-5-oxo-5h-pyrido[3,2-a]phenoxazine-3-carboxylic acid;PIRENOXINE;1-Hydroxy-3-carboxy-5H-pyrido[3,2-a]phenoxazin-5-one;1-Hydroxy-5H-pyrido[3,2-a]phenoxazin-5-one-3-carboxylic acid;5H-Pyrido[3,2-a]phenoxazine-3-carboxylic acid, 1-hydroxy-5-oxo- | | CAS: | 1043-21-6 | | MF: | C16H8N2O5 | | MW: | 308.25 | | EINECS: | 213-872-4 | | Product Categories: | | | Mol File: | 1043-21-6.mol |  |
| | Pirenoxine Chemical Properties |
| Melting point | 247-248°C | | Boiling point | 699.7±55.0 °C(Predicted) | | density | 1.70±0.1 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | Aqueous Base (Slightly) | | form | Solid | | pka | 2.63±0.20(Predicted) | | color | Very Dark Red to Very Dark Brown | | InChI | InChI=1S/C16H8N2O5/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12/h1-6H,(H,18,19)(H,21,22) | | InChIKey | OKPNYGAWTYOBFZ-UHFFFAOYSA-N | | SMILES | C12=C(O)C=C(C(O)=O)N=C1C(=O)C=C1C2=NC2=C(C=CC=C2)O1 | | CAS DataBase Reference | 1043-21-6(CAS DataBase Reference) |
| | Pirenoxine Usage And Synthesis |
| Uses | antiviral | | Uses | Pirenoxine, is a medication used in the possible treatment and prevention of cataracts. | | Definition | ChEBI: Pirenoxine is an organic molecular entity. | | in vivo | Pirenoxine (0.005% pirenoxine; eye drop) suppresses lens hardening and prevents the progression of presbyopia[2]. | Animal Model: | Six-week-old male Sprague-Dawley rats[2] | | Dosage: | 0.005% pirenoxine | | Administration: | Eye drop | | Result: | Significantly suppressed lens hardening. |
|
| | Pirenoxine Preparation Products And Raw materials |
|